Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by KELLY K HUNT and MEDIGET TESHOME.
KELLY K HUNT
Connection Strength
4.625
MEDIGET TESHOME
  1. Neoadjuvant therapy in the treatment of breast cancer. Surg Oncol Clin N Am. 2014 Jul; 23(3):505-23.
    View in: PubMed
    Score: 0.480
  2. Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2024 Oct 23.
    View in: PubMed
    Score: 0.249
  3. ASO Visual Abstract: Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Ann Surg Oncol. 2024 Oct 23.
    View in: PubMed
    Score: 0.249
  4. Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Ann Surg Oncol. 2024 Oct 17.
    View in: PubMed
    Score: 0.248
  5. ASO Author Reflections: Evolving Multidisciplinary Decision Making for Early-Stage, HER2-Positive Breast Cancer. Ann Surg Oncol. 2024 Dec; 31(13):8908-8909.
    View in: PubMed
    Score: 0.246
  6. Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2024 Dec; 31(13):8795-8801.
    View in: PubMed
    Score: 0.246
  7. Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection. Ann Surg Oncol. 2024 Oct; 31(11):7264-7270.
    View in: PubMed
    Score: 0.244
  8. Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities. Ann Surg Oncol. 2024 Oct; 31(11):7326-7334.
    View in: PubMed
    Score: 0.244
  9. ASO Author Reflections: Management of Inflammatory Breast Cancer: No Role for Surgical De-escalation Yet. Ann Surg Oncol. 2024 Oct; 31(11):7335-7336.
    View in: PubMed
    Score: 0.244
  10. Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol. 2021 Oct; 28(10):5626-5634.
    View in: PubMed
    Score: 0.198
  11. Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2021 Oct; 28(10):5477-5485.
    View in: PubMed
    Score: 0.198
  12. Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):979.
    View in: PubMed
    Score: 0.190
  13. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann Surg Open. 2020 Dec; 1(2).
    View in: PubMed
    Score: 0.190
  14. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3510-3516.
    View in: PubMed
    Score: 0.172
  15. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg. 2017 03; 265(3):574-580.
    View in: PubMed
    Score: 0.146
  16. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis. Ann Surg Oncol. 2016 May; 23(5):1508-14.
    View in: PubMed
    Score: 0.136
  17. Assessing Surgeon Familiarity with the Commission on Cancer Operative Standards for Cancer Surgery. Ann Surg Oncol. 2024 Oct; 31(10):6378-6386.
    View in: PubMed
    Score: 0.061
  18. ASO Author Reflections: The Path to Standardizing Surgical Cancer Care in the USA. Ann Surg Oncol. 2024 Oct; 31(10):6406-6407.
    View in: PubMed
    Score: 0.061
  19. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Oct; 31(11):7339-7346.
    View in: PubMed
    Score: 0.061
  20. Correction: Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. Ann Surg Oncol. 2024 Jul; 31(7):4565.
    View in: PubMed
    Score: 0.061
  21. Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation. JAMA Netw Open. 2024 Jun 03; 7(6):e2418486.
    View in: PubMed
    Score: 0.060
  22. Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Feb; 31(2):974-980.
    View in: PubMed
    Score: 0.058
  23. Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. Ann Surg Oncol. 2024 Jan; 31(1):6-9.
    View in: PubMed
    Score: 0.058
  24. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer? Ann Surg Oncol. 2023 Dec; 30(13):8327-8334.
    View in: PubMed
    Score: 0.057
  25. Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. Ann Surg Oncol. 2023 Nov; 30(12):7015-7025.
    View in: PubMed
    Score: 0.057
  26. Operative standards for sentinel lymph node biopsy and axillary lymphadenectomy for breast cancer: review of the American College of Surgeons commission on cancer standards 5.3 and 5.4. Surgery. 2023 09; 174(3):717-721.
    View in: PubMed
    Score: 0.056
  27. American College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer. J Am Coll Surg. 2022 06 01; 234(6):1249-1253.
    View in: PubMed
    Score: 0.052
  28. Impact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education. J Surg Oncol. 2021 Dec; 124(7):989-994.
    View in: PubMed
    Score: 0.050
  29. American College of Surgeons Commission on Cancer Standard for Curative-intent Pulmonary Resection. Ann Thorac Surg. 2022 01; 113(1):5-8.
    View in: PubMed
    Score: 0.049
  30. Clinical trials-Designing, implementing, and collaborating. J Surg Oncol. 2020 Jul; 122(1):25-28.
    View in: PubMed
    Score: 0.045
  31. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors. Ann Surg Oncol. 2020 Apr; 27(4):1013-1022.
    View in: PubMed
    Score: 0.045
  32. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 05; 267(5):946-951.
    View in: PubMed
    Score: 0.040
  33. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg. 2017 07 01; 152(7):665-670.
    View in: PubMed
    Score: 0.037
  34. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol. 2017 Mar; 24(3):652-659.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.